Back
Chemomab Therapeutics Ltd. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
17
CMMB
Chemomab Therapeutics Ltd.
Last Price:
$1.90
Seasonality Move:
25.93%
7 Day Trial
ALL ACCESS PASS
$
7
Chemomab Therapeutics Ltd. Stock Forecast
-
Is Chemomab Therapeutics Ltd. Stock Undervalued?The current Chemomab Therapeutics Ltd. [CMMB] share price is $1.89. The Score for CMMB is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
-
CMMB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Chemomab Therapeutics Ltd. Stock Go Up Next Year?
Data Unavailable
Chemomab Therapeutics Ltd. Stock Rating
Data Unavailable
Chemomab Therapeutics Ltd. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Israel
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
chemomab.com
52-Week Data
52-Week High:
9.84
52-Week Low:
1.73
Prediction Charts
Market Cap:
11.6M
Price in USD:
1.89
Volume:
138.7K
Beta:
0.66
Technical Analysis
SMA50:
2.72
SMA100:
2.98
SMA200:
3.94
52-Wk Change:
-70.83%
Stock Predictions
-
Is Chemomab Therapeutics Ltd. stock public?Yes, Chemomab Therapeutics Ltd. is a publicly traded company.
-
What is the Chemomab Therapeutics Ltd. stock quote today?The Chemomab Therapeutics Ltd. stock price is 1.89 USD today.
-
How to buy Chemomab Therapeutics Ltd. stock online?You can buy Chemomab Therapeutics Ltd. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 2.65 | 2.53 | 2.67 | 2.50 |
| Dec-3 | 2.53 | 2.49 | 2.68 | 2.48 |
| Dec-4 | 2.54 | 2.47 | 2.64 | 2.42 |
| Dec-5 | 2.54 | 2.48 | 2.62 | 2.45 |
| Dec-8 | 2.47 | 2.74 | 2.77 | 2.44 |
| Dec-9 | 2.73 | 2.60 | 2.74 | 2.49 |
| Dec-10 | 2.60 | 2.47 | 2.71 | 2.36 |
| Dec-11 | 2.45 | 2.36 | 2.50 | 2.36 |
| Dec-12 | 2.41 | 2.22 | 2.45 | 2.21 |
| Dec-15 | 2.27 | 2.06 | 2.34 | 2.01 |
| Dec-16 | 2.12 | 2.06 | 2.17 | 2.02 |
| Dec-17 | 2.08 | 2.08 | 2.15 | 1.96 |
| Dec-18 | 2.10 | 1.92 | 2.21 | 1.91 |
| Dec-19 | 2.01 | 1.89 | 2.15 | 1.73 |
Chemomab Therapeutics Ltd. Earnings
Data Unavailable
Chemomab Therapeutics Ltd. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and a decrease next year of $0.12 per share.
* Chemomab Therapeutics Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.